<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title>Offerings - Quantisnow</title>
    <description>Equity and debt offerings as they&apos;re announced.</description>
    <link>https://www.quantisnow.com/news/offerings</link>
    <language>en-us</language>
    <lastBuildDate>Wed, 30 Sep 2026 16:27:39 GMT</lastBuildDate>
    <item>
      <title>Top Ships Inc. Announces Closing of the Acquisition of three High Specification Newbuilding MR Tankers</title>
      <description>ATHENS, Greece, Sept.  30, 2026  (GLOBE NEWSWIRE) -- TOP Ships Inc. (the &quot;Company&quot; or &quot;TOP Ships&quot;) (NYSE:TOPS), an international owner and operator of modern, fuel-efficient &quot;ECO&quot; tanker vessels, announced today the closing of the previously announced share purchase agreement dated July 28, 2026 (the &quot;SPA&quot;) with a related party (the &quot;Seller&quot;), pursuant to which the Company acquired the shares of three companies (the &quot;SPVs&quot;), each of which is party to one shipbuilding contract with an established, world-class shipbuilder for the construction of three high-specification, ECO, scrubber-fitted MR Product Tankers to be delivered in 2029. The SPVs have secured time charter employment for the vesse</description>
      <link>https://www.quantisnow.com/insight/top-ships-inc-announces-closing-of-the-acquisition-of-three-6730342</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/top-ships-inc-announces-closing-of-the-acquisition-of-three-6730342</guid>
      <pubDate>Wed, 30 Sep 2026 14:45:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours</title>
      <description>DENVER, Sept.  30, 2026  (GLOBE NEWSWIRE) -- (247marketnews.com) -- The biotech market is heading into a stretch of unusually dense catalysts, with regulatory meetings, Phase 2 readouts, potential Phase 3 transitions and blockbuster cardiometabolic data converging for NeOnc Technologies Holdings (NASDAQ:NTHI), Connect Biopharma (NASDAQ:CNTB), Valion Bio (NASDAQ:VBIO), and Eli Lilly and Company (NYSE:LLY).  NeOnc: November FDA Meeting Puts NEO212 Under the Microscope  NeOnc (NASDAQ:NTHI) is moving toward a potentially important regulatory checkpoint with an in-person End-of-Phase 1 Type B meeting with the U.S. Food and Drug Administration scheduled for November 17, 2026. The meeting concerns </description>
      <link>https://www.quantisnow.com/insight/3-biotech-stocks-throwing-their-weight-around-and-another-that-6730330</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/3-biotech-stocks-throwing-their-weight-around-and-another-that-6730330</guid>
      <pubDate>Wed, 30 Sep 2026 14:22:13 GMT</pubDate>
    </item>
    <item>
      <title>Neo-Concept International Group Holdings Ltd Announces Pricing of $2.0 Million Registered Direct Offering</title>
      <description>HONGKONG, Sept.  30, 2026  (GLOBE NEWSWIRE) --  Neo-Concept International Group Holdings Ltd (NASDAQ:NCI) (&quot;Neo-Concept&quot; or the &quot;Company&quot;), a one-stop apparel solution services provider, today announced that it has entered into securities purchase agreements with certain institutional investor for the purchase and sale of 2,000,000 of the Company’s Class A ordinary shares (the &quot;Class A ordinary shares&quot;) (or pre-funded warrants in lieu of Class A ordinary shares), at an offering price of $1.00 per share (or $0.99 per pre-funded warrant, which is equal to the per share offering price minus the $0.01 per share exercise price of each pre-funded warrant), in a registered direct offering(the &quot;Offe</description>
      <link>https://www.quantisnow.com/insight/neo-concept-international-group-holdings-ltd-announces-pricing-of-20-million-6730290</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/neo-concept-international-group-holdings-ltd-announces-pricing-of-20-million-6730290</guid>
      <pubDate>Wed, 30 Sep 2026 13:35:11 GMT</pubDate>
    </item>
    <item>
      <title>Digimarc Announces Registered Direct Offering of Common Stock</title>
      <description>
Digimarc Corporation (NASDAQ:DMRC), a leading provider in digital identity and authentication solutions, today announced that it has entered into purchase agreements to sell common shares in a registered direct offering led by an existing Digimarc investor.


Needham &amp; Company acted as sole placement agent in the registered direct offering.


The gross proceeds to Digimarc from the offering are expected to be approximately $18.2 million. The offering is expected to close on or about September 30, 2026, subject to the satisfaction of customary closing conditions. Digimarc intends to use the net proceeds from the offering for general corporate purposes.


The shares described above are being </description>
      <link>https://www.quantisnow.com/insight/digimarc-announces-registered-direct-offering-of-common-stock-6730258</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/digimarc-announces-registered-direct-offering-of-common-stock-6730258</guid>
      <pubDate>Wed, 30 Sep 2026 13:15:00 GMT</pubDate>
    </item>
    <item>
      <title>TGE&apos;s profit surged by 9.9 times, with total assets at US$1.8bn and net assets at US$932m</title>
      <description>The Generation Essentials Group (&quot;TGE&quot;orthe&quot;Group&quot;orthe &quot;Company&quot;)InterimResults2026Key Highlights:Revenue from contracts with customers grew by 35.8% to US$30.8 million Hospitality arm&apos;s revenue surged by 59.8% following strategic acquisitions Net profit improved significantly to US$22.8 millionEPS increased by 366.7% to US$0.56/shareTotal Assets amounted to US$1.8 billion (US$37.2/share)Net asset value amounted to US$932.5 million (US$19.2/share)PARIS and NEW YORK and LONDON, Sept. 30, 2026 /PRNewswire/ -- The Generation Essentials Group (&quot;, TGE&quot;, , the &quot;, Company&quot;, , or &quot;, we&quot;, , NYSE:TGE, LSE: TGE), jointly established by AMTD Group, AMTD IDEA Group (NYSE:AMTD, SGX: HKB)) and AMTD Digita</description>
      <link>https://www.quantisnow.com/insight/tges-profit-surged-by-99-times-with-total-assets-at-6729819</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/tges-profit-surged-by-99-times-with-total-assets-at-6729819</guid>
      <pubDate>Wed, 30 Sep 2026 10:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering</title>
      <description>BOSTON, Sept.  30, 2026  (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the pricing of its previously announced registered public offering (the &quot;Offering&quot;) of 36,047,919 shares of its common stock, or in lieu of common stock to certain investors, 1,883,121 pre-funded warrants to purchase shares of common stock, and accompanying common warrants to purchase 49,310,352 shares of common stock at an exercise price of $3.50. The combined public offering price for each share of common stock and accompanying common warrant is $2.90, and the combined public offering price for each</description>
      <link>https://www.quantisnow.com/insight/pyxis-oncology-announces-pricing-of-up-to-2826-million-public-6729717</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/pyxis-oncology-announces-pricing-of-up-to-2826-million-public-6729717</guid>
      <pubDate>Wed, 30 Sep 2026 05:11:09 GMT</pubDate>
    </item>
    <item>
      <title>Draganfly Announces Closing of US$10 Million Strategic Investment</title>
      <description>TAMPA, Fla., Sept.  29, 2026  (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) (&quot;Draganfly&quot; or the &quot;Company&quot;), an industry-leading developer of drone solutions, systems and technologies, today announced the closing of its previously announced registered direct offering of 1,869,159 common shares of the Company at a price of US$5.35, for gross proceeds of approximately US$10 million, before deducting placement agent discounts and offering expenses (the &quot;Investment&quot;).    Jett Capital Advisors, LLC and Northland Capital Markets acted as joint-lead placement agents for the Investment.    Draganfly intends to use the net proceeds to accelerate the development of advanced str</description>
      <link>https://www.quantisnow.com/insight/draganfly-announces-closing-of-us10-million-strategic-investment-6729693</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/draganfly-announces-closing-of-us10-million-strategic-investment-6729693</guid>
      <pubDate>Wed, 30 Sep 2026 01:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Pyxis Oncology Announces Proposed Public Offering</title>
      <description>BOSTON, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that it has commenced a registered public offering (the &quot;Offering&quot;) of (i) shares of its common stock, or in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock, and (ii) accompanying common warrants to purchase shares of common stock. Each share of common stock and each pre-funded warrant will be sold together with a common warrant to purchase one share of common stock.  The common warrants will become exercisable only upon approval by the Company&apos;s stock</description>
      <link>https://www.quantisnow.com/insight/pyxis-oncology-announces-proposed-public-offering-6729319</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/pyxis-oncology-announces-proposed-public-offering-6729319</guid>
      <pubDate>Tue, 29 Sep 2026 20:24:44 GMT</pubDate>
    </item>
    <item>
      <title>Agility Robotics Announces New Directors for Planned Public-Company Board</title>
      <description>
Technology, Business and Legal Leaders Bring Decades of Experience in Global Commercialization, Strategic Partnerships and Corporate Governance as Agility Prepares to Scale Humanoid Robotics


Agility Robotics, a leading humanoid robotics and physical AI company, today announced that Merline Saintil, Derek Aberle and Pierre Gentin are expected to join its board of directors following the completion of its previously announced business combination with Churchill Capital Corp XI (NASDAQ:CCXI). The new directors will serve alongside Agility CEO Peggy Johnson and co-founder Damion Shelton, both of whom will continue as members of the board.

This press release features multimedia. View the full</description>
      <link>https://www.quantisnow.com/insight/agility-robotics-announces-new-directors-for-planned-public-company-board-6729176</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/agility-robotics-announces-new-directors-for-planned-public-company-board-6729176</guid>
      <pubDate>Tue, 29 Sep 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering</title>
      <description>SINGAPORE, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) (&quot;Cuprina&quot; or &quot;the Company&quot;), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it closed the sale of an additional 648,373 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriter’s over-allotment option granted in connection with the Company’s public offering (&quot;PO&quot;, together with such over-allotment closing, the &quot;Offering&quot;), at a public offering price of $1.15 per share, for a total of approximately $745,629 of gross proceeds to the Company, before d</description>
      <link>https://www.quantisnow.com/insight/cuprina-holdings-cayman-limited-announces-closing-of-underwriters-over-allotment-option-6729124</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cuprina-holdings-cayman-limited-announces-closing-of-underwriters-over-allotment-option-6729124</guid>
      <pubDate>Tue, 29 Sep 2026 20:00:00 GMT</pubDate>
    </item>
    <item>
      <title>SIBANYE-STILLWATER ANNOUNCES FILING OF EARLY WARNING EXIT REPORT IN RESPECT OF GENERATION MINING LIMITED</title>
      <description>JOHANNESBURG, South Africa, Sept. 29, 2026 /CNW/ -- Sibanye Stillwater Limited&apos;s (JSE: SSW) (NYSE:SBSW) wholly owned subsidiary Stillwater Canada Inc. (&quot;Sibanye-Stillwater&quot;) announces that it has filed an early warning report in respect of its shareholding in Generation Mining Limited (&quot;Generation Mining&quot; or the &quot;Issuer&quot;) following the decrease of its securityholding percentage below 10% of the issued and outstanding common shares of Generation Mining (the &quot;Common Shares&quot;) as a result of the Issuer&apos;s recently completed financing.
On September 21, 2026, Generation Mining completed a bought deal public offering of 312,500,000 Common Shares and a concurrent private placement of 62,500,000 Commo</description>
      <link>https://www.quantisnow.com/insight/sibanye-stillwater-announces-filing-of-early-warning-exit-report-in-respect-6728967</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sibanye-stillwater-announces-filing-of-early-warning-exit-report-in-respect-6728967</guid>
      <pubDate>Tue, 29 Sep 2026 16:41:00 GMT</pubDate>
    </item>
    <item>
      <title>High-Stakes October has these Biotechs Entering Crucial Stretch</title>
      <description>DENVER, Sept.  29, 2026  (GLOBE NEWSWIRE) -- (247marketnews.com) -- The biotechnology market is heading into a catalyst-heavy stretch, with Iovance Biotherapeutics (NASDAQ:IOVA), NeOnc Technologies Holdings (NASDAQ:NTHI), and Summit Therapeutics (NASDAQ:SMMT), moving from promises and pipelines toward events that could materially reshape how investors view their businesses.  Iovance Boosts 2026 Revenue Guidance as Amtagvi Demand Surges  For Iovance (NASDAQ:IOVA), the headline is revenue. The company raised its full-year 2026 total revenue guidance to $410 million to $420 million, up $55 million at the midpoint from its previous $350 million to $370 million range. That new outlook implies nea</description>
      <link>https://www.quantisnow.com/insight/high-stakes-october-has-these-biotechs-entering-crucial-stretch-6728952</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/high-stakes-october-has-these-biotechs-entering-crucial-stretch-6728952</guid>
      <pubDate>Tue, 29 Sep 2026 16:12:58 GMT</pubDate>
    </item>
    <item>
      <title>E-Power Inc. Announces Pricing of Approximately $1.87 Million Registered Direct Offering</title>
      <description>DOVER, USA, Sept.  29, 2026  (GLOBE NEWSWIRE) --  E-Power Inc. (the &quot;Company&quot; or &quot;E-Power&quot;) (NASDAQ:EPOW), a provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced that it has entered into a securities purchase agreement with a certain non-U.S. investor to purchase approximately $1.87 million of its Class A ordinary shares (the &quot;Ordinary Shares&quot;) (and pre-funded warrants in lieu thereof) in a registered direct offering.  Pursuant to the securities purchase agreement, the Company agreed to issue and sell 229,097 Ordinary Shares, par value $0.0025 per share, at a purchase price of $3.60 per share, and pre-funded warrants to purchase up to 292,393 </description>
      <link>https://www.quantisnow.com/insight/e-power-inc-announces-pricing-of-approximately-187-million-registered-direct-6728943</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/e-power-inc-announces-pricing-of-approximately-187-million-registered-direct-6728943</guid>
      <pubDate>Tue, 29 Sep 2026 15:59:00 GMT</pubDate>
    </item>
    <item>
      <title>NeOnc’s Powerful Brain Cancer Pipeline Advances</title>
      <description>DALLAS, Sept.  29, 2026  (GLOBE NEWSWIRE) -- (www.InvestorsTape.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is heading toward another potentially important regulatory milestone, with the U.S. Food and Drug Administration scheduled to meet with the company on November 17, 2026, for an in-person End-of-Phase 1 Type B meeting concerning NEO212, its oral perillyl alcohol-temozolomide conjugate being developed for aggressive central nervous system cancers.  NeOnc plans to seek agency feedback on the proposed patient population, Phase 2 trial design, endpoints, dose selection and the evidence that could ultimately support a future marketing application. The company also intends to discuss po</description>
      <link>https://www.quantisnow.com/insight/neoncs-powerful-brain-cancer-pipeline-advances-6728724</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/neoncs-powerful-brain-cancer-pipeline-advances-6728724</guid>
      <pubDate>Tue, 29 Sep 2026 12:52:25 GMT</pubDate>
    </item>
    <item>
      <title>Greenland Mines Brings Total New Capital to Over $59 Million with Above-Market Raise from Existing Shareholders</title>
      <description>Following termination of ATM, Company has substantially utilized its shelf capacity  Company also strengthens Board with the addition of two seasoned mining directors  CHARLOTTE, N.C., Sept.  29, 2026  (GLOBE NEWSWIRE) -- via IBN – Greenland Mines Ltd (&quot;Greenland Mines&quot; or the &quot;Company&quot;) (NASDAQ:GRML, FSE: HK6)), a Greenland-focused mineral resource development company, today announced that it has raised over $17 million through a registered direct offering of common stock at a purchase price of $13.00 per share, bringing total capital raised by the Company over the past week to over $59 million. The financing materially strengthens the Company’s balance sheet and provides the capital requir</description>
      <link>https://www.quantisnow.com/insight/greenland-mines-brings-total-new-capital-to-over-59-million-6728683</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/greenland-mines-brings-total-new-capital-to-over-59-million-6728683</guid>
      <pubDate>Tue, 29 Sep 2026 12:35:33 GMT</pubDate>
    </item>
    <item>
      <title>Humanoid Global Highlights MBody AI’s Completion of Nasdaq Transaction and Commercial Robotics Deployment at Mohegan Sun</title>
      <description>Vancouver, BC, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (&quot;Humanoid Global&quot; or the &quot;Company&quot;) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in humanoid robotics and embodied artificial intelligence (&quot;AI&quot;), is pleased to highlight recent corporate and commercial developments announced by MBody AI Ltd. (&quot;MBody AI&quot;) (NASDAQ:MBAI), a portfolio company in which Humanoid Global holds a minority equity interest.MBody AI announced that, on August 26, 2026, Check-Cap Ltd. completed its business combination with MBody AI Corp. Under the transaction, MBody AI Corp. became a wholly</description>
      <link>https://www.quantisnow.com/insight/humanoid-global-highlights-mbody-ais-completion-of-nasdaq-transaction-and-6728664</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/humanoid-global-highlights-mbody-ais-completion-of-nasdaq-transaction-and-6728664</guid>
      <pubDate>Tue, 29 Sep 2026 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Propanc Biopharma Provides Corporate Update &amp; Year-End June 30, 2025-26, Financial Results</title>
      <description>MELBOURNE, Australia, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (NASDAQ:PPCB) (&quot;Propanc&quot; or the &quot;Company&quot;), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced an update on corporate progress and reported year-end financial results as of June 30, 2026 (Year end June 30).  CORPORATE HIGHLIGHTS  To commence a world-first Phase 1b FIH study of PRP in Q1, 2027  The multicenter, open-label study will enroll up to 50 patients with advanced solid tumors, including pancreatic, ovarian, and refractory prostate cancers, at trial centers across Australia. The two-part design, dose escalati</description>
      <link>https://www.quantisnow.com/insight/propanc-biopharma-provides-corporate-update-year-end-june-30-2025-26-financial-6728650</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/propanc-biopharma-provides-corporate-update-year-end-june-30-2025-26-financial-6728650</guid>
      <pubDate>Tue, 29 Sep 2026 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Turbo Energy Delivers Record First-Half 2026 Revenue and Swings to Positive Operating Income</title>
      <description>VALENCIA, Spain, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ:TURB) (&quot;Turbo Energy&quot; or the &quot;Company&quot;), a technology-driven integrator of energy storage and intelligent energy-management solutions, today reported its unaudited consolidated financial results for the six months ended June 30, 2026.  Total revenue for the first half of 2026 increased 172.7% to €15,033,238 (approximately $17.2 million), compared with €5,512,458 in the first half of 2025. The Company achieved positive operating income of €510,542 (approximately $0.58 million) in the first half of 2026, compared with an operating loss of €1,164,274 in the prior-year period, representing a year-over-year improveme</description>
      <link>https://www.quantisnow.com/insight/turbo-energy-delivers-record-first-half-2026-revenue-and-swings-to-6728603</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/turbo-energy-delivers-record-first-half-2026-revenue-and-swings-to-6728603</guid>
      <pubDate>Tue, 29 Sep 2026 12:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering</title>
      <description>
$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of the warrants


Lantern Pharma Inc. (NASDAQ:LTRN) (&quot;Lantern&quot;, the &quot;Company&quot; or &quot;we&quot;), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 3,669,725 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.09 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. In addition, in a concurrent private placement, the Company</description>
      <link>https://www.quantisnow.com/insight/lantern-pharma-inc-announces-up-to-8-million-registered-direct-6728585</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/lantern-pharma-inc-announces-up-to-8-million-registered-direct-6728585</guid>
      <pubDate>Tue, 29 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cushman &amp; Wakefield Earns Upgrade to ‘Ba3’ Rating from Moody’s Ratings, Outlook Stable</title>
      <description>
Cushman &amp; Wakefield (NYSE:CWK), a leading global commercial real estate services firm, announced today that Moody’s Ratings (&quot;Moody’s&quot;) upgraded CWK’s corporate family rating to Ba3 from B1. The upgrade reflects sustained improvement in the company’s credit profile and is the highest rating Moody’s has assigned to Cushman &amp; Wakefield since its initial public offering in 2018.


&quot;This upgrade from Moody’s reflects the discipline and execution our team has delivered over the past several years, including meaningful improvements in free cash flow, a more efficient operating platform and significant leverage reduction, all while driving strong earnings growth,&quot; said Michelle MacKay, Chief Execu</description>
      <link>https://www.quantisnow.com/insight/cushman-wakefield-earns-upgrade-to-ba3-rating-from-moodys-ratings-6728491</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cushman-wakefield-earns-upgrade-to-ba3-rating-from-moodys-ratings-6728491</guid>
      <pubDate>Mon, 28 Sep 2026 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Beasley Broadcast Group Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement</title>
      <description>NAPLES, Fla., Sept. 29, 2026 /PRNewswire/ -- Beasley Broadcast Group, Inc. (NASDAQ:BBGI), a multi-platform media company, announced today that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of (i) 357,000 shares of Class A Common Stock, par value $0.001 per share (&quot;Class A Common Stock&quot;), of the Company (or common stock equivalents in lieu thereof) at a purchase price of $14.00 per share in a registered direct offering and (ii) unregistered warrants to purchase up to 357,000 shares of Class A Common Stock in a concurrent private placement (the &quot;Common Warrants&quot;).
    
                
                    
                
  </description>
      <link>https://www.quantisnow.com/insight/beasley-broadcast-group-announces-pricing-of-50-million-registered-direct-6728460</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/beasley-broadcast-group-announces-pricing-of-50-million-registered-direct-6728460</guid>
      <pubDate>Tue, 29 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>One and One Green Technologies Reports First Half 2026 Results</title>
      <description>Revenues Up 18.7% to $33.4 MillionNet Income Up 17.4% to $4.5 Million Copper Alloy Revenue Up 39%  SAN RAFAEL, BULACAN, PHILIPPINES, Sept.  29, 2026  (GLOBE NEWSWIRE) -- One and One Green Technologies, Inc. (NASDAQ:YDDL) (&quot;One and One&quot; or the &quot;Company&quot;), a waste materials and scrap metal recycler that produces copper alloy, aluminum alloy and brass alloy ingots in the Philippines, today reported financial results for the six months ended June 30, 2026.  Revenues rose 18.7% to $33.38 million from $28.13 million, and net income rose 17.4% to $4.49 million from $3.83 million. The increase occurred despite a 10.4% decrease in total material shipped, as the Company reallocated processing capacity</description>
      <link>https://www.quantisnow.com/insight/one-and-one-green-technologies-reports-first-half-2026-results-6728423</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/one-and-one-green-technologies-reports-first-half-2026-results-6728423</guid>
      <pubDate>Tue, 29 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality</title>
      <description>CLEARWATER, Fla., Sept.  29, 2026  (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (&quot;Apyx Medical&quot; or the &quot;Company&quot;), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced results from a prospective clinical study evaluating the effects of Renuvion helium plasma radiofrequency technology on biological markers of skin quality. The study was published in Plastic and Reconstructive Surgery—Global Open 1.  The study provides new human tissue evidence indicating that Renuvion treatment may produce measurable changes beneath the surface of the skin that support improvements in skin quality observed by physicians and</description>
      <link>https://www.quantisnow.com/insight/apyx-medical-announces-new-clinical-study-demonstrating-renuvions-impact-on-6728402</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/apyx-medical-announces-new-clinical-study-demonstrating-renuvions-impact-on-6728402</guid>
      <pubDate>Tue, 29 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet</title>
      <description>Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders&apos; EquityVANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the &quot;Company&quot;) (NASDAQ:IMCC), today announced that, further to its press releases dated June 18, 2026 and August 17, 2026, it has completed the previously announced transaction contemplated by the definitive share purchase agreement dated August 16, 2026 (the &quot;Share Purchase Agreement&quot;) among the Company, Slil.com Holding Ltd. (&quot;Slil&quot;) and I.M.C. Holdings Ltd. (&quot;IMC Holdings&quot;), pursuant to which the Company sold to Slil all of the issued and outstanding shares of IMC Holdings (the &quot;Transaction&quot;). The Transac</description>
      <link>https://www.quantisnow.com/insight/im-cannabis-announces-closing-of-the-sale-of-imc-holdings-6728353</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/im-cannabis-announces-closing-of-the-sale-of-imc-holdings-6728353</guid>
      <pubDate>Tue, 29 Sep 2026 11:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock</title>
      <description>LOS ANGELES, Sept.  29, 2026  (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (&quot;ImmixBio&quot;, &quot;Company&quot;, &quot;we&quot; or &quot;us&quot; or &quot;IMMX&quot;), a global leader in relapsed/refractory AL Amyloidosis, today announced the pricing of an underwritten registered offering of 11,363,637 shares of its common stock at a public offering price of $11.00 per share. The gross proceeds from this offering are expected to be $125 million, before deducting underwriting discounts and commissions and offering expenses payable by the Company. The offering is expected to close on or about September 30, 2026, subject to the satisfaction of customary closing conditions.  Immix intends to use the net proceeds from this offering to fund NX</description>
      <link>https://www.quantisnow.com/insight/immix-biopharma-announces-pricing-of-125-million-underwritten-offering-of-6728349</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/immix-biopharma-announces-pricing-of-125-million-underwritten-offering-of-6728349</guid>
      <pubDate>Tue, 29 Sep 2026 11:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Private Markets Industry Leader Mario Giannini to Retire from Hamilton Lane</title>
      <description>CONSHOHOCKEN, Pa., Sept. 29, 2026 /PRNewswire/ -- Hamilton Lane (NASDAQ:HLNE), a leading global private markets investment management firm, today announced that Mario Giannini, Executive Co-Chairman, will retire effective March 31, 2027. His retirement concludes more than three decades with the firm and a career that has had a lasting impact on Hamilton Lane and the broader private markets industry.
Giannini joined Hamilton Lane in 1993 as the firm&apos;s third employee. Over the course of his tenure, he played an instrumental role in shaping the firm&apos;s strategy and growth, including its expansion into new business lines and geographies and its initial public offering in 2017. He served as Chief </description>
      <link>https://www.quantisnow.com/insight/private-markets-industry-leader-mario-giannini-to-retire-from-hamilton-6728338</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/private-markets-industry-leader-mario-giannini-to-retire-from-hamilton-6728338</guid>
      <pubDate>Tue, 29 Sep 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NewGen Announces Pricing of $1.25 Million Public Offering</title>
      <description>BANGKOK, Sept.  29, 2026  (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) (the &quot;Company&quot;), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company.  The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Comm</description>
      <link>https://www.quantisnow.com/insight/newgen-announces-pricing-of-125-million-public-offering-6728179</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/newgen-announces-pricing-of-125-million-public-offering-6728179</guid>
      <pubDate>Tue, 29 Sep 2026 02:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Magic Empire Global Limited Announces Pricing of US$3 Million Registered Direct Offering</title>
      <description>Hong Kong, Sept.  28, 2026  (GLOBE NEWSWIRE) -- Magic Empire Global Limited (NASDAQ:MEGL) (the &quot;Company&quot;) today announced the pricing of a registered direct offering (the &quot;Offering&quot;) of 2,678,572 units (each a &quot;Unit&quot;) at an offering price of US$1.12 per Unit.  Each Unit consists of one Class A ordinary share of the Company, no par value (each, a &quot;Class A Ordinary Share&quot;) and one warrant to purchase one Class A Ordinary Share (or up to nine Class A Ordinary Shares pursuant to the alternative cashless exercise (zero exercise price option) (each, a &quot;Warrant&quot;). Each Warrant will have an exercise price of US$1.12 per Class A Ordinary Share and will be exercisable beginning on the issuance date an</description>
      <link>https://www.quantisnow.com/insight/magic-empire-global-limited-announces-pricing-of-us3-million-registered-6728068</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/magic-empire-global-limited-announces-pricing-of-us3-million-registered-6728068</guid>
      <pubDate>Mon, 28 Sep 2026 21:29:00 GMT</pubDate>
    </item>
    <item>
      <title>EigenQ and Silicon Valley Acquisition Corp. Advance Proposed Business Combination with Public Filing of Registration Statement on Form S-4</title>
      <description>Public filing marks another milestone toward completion of the previously announced business combinationAUSTIN, Texas and PALO ALTO, Calif., Sept. 28, 2026 /PRNewswire/ -- EigenQ, Inc. (&quot;EigenQ&quot; or the &quot;Company&quot;) and Silicon Valley Acquisition Corp. (NASDAQ:SVAQ) (&quot;SVAQ&quot;) today announced the public filing with the U.S. Securities and Exchange Commission (&quot;SEC&quot;) of a registration statement on Form S-4 (the &quot;Registration Statement&quot;) in connection with their previously announced proposed business combination (the &quot;Business Combination&quot;).
    
                
                    
                
    
The Registration Statement includes a preliminary proxy statement/prospectus relating to the p</description>
      <link>https://www.quantisnow.com/insight/eigenq-and-silicon-valley-acquisition-corp-advance-proposed-business-combination-6728008</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/eigenq-and-silicon-valley-acquisition-corp-advance-proposed-business-combination-6728008</guid>
      <pubDate>Mon, 28 Sep 2026 21:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters&apos; Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes</title>
      <description>Gross Proceeds to Viking Approximately $575 MillionSAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the closing of its concurrent upsized public offerings of 9,035,714 shares of common stock, at a public offering price of $35.00 per share, and $258.75 million aggregate principal amount of 2.00% convertible senior notes due 2032 (the &quot;notes&quot;), which included the full exercise by the underwriters of the common stock offering of their option to purchase an additional 1,178,571 shares of common stock, and the full exerci</description>
      <link>https://www.quantisnow.com/insight/viking-therapeutics-announces-closing-of-concurrent-upsized-offerings-of-common-6727848</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/viking-therapeutics-announces-closing-of-concurrent-upsized-offerings-of-common-6727848</guid>
      <pubDate>Mon, 28 Sep 2026 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results</title>
      <description>LITTLETON, Mass., Sept.  28, 2026  (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced financial results for its fourth quarter and fiscal year ended June 30, 2026.  Q4 2026 Financial Highlights (3 Months Ended June 30, 2026)  Revenue was $8.8 million, a quarterly record, compared to $6.2 million in the same quarter of the previous fiscal year, representing growth of approximately 42%, and compared to $8.7 million in the most recent sequential quarter.Production revenue was $8.0 million, a quarterly record, compared to $5.1 million in the sam</description>
      <link>https://www.quantisnow.com/insight/precision-optics-reports-fourth-quarter-and-fiscal-year-2026-financial-6727835</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/precision-optics-reports-fourth-quarter-and-fiscal-year-2026-financial-6727835</guid>
      <pubDate>Mon, 28 Sep 2026 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Arbe Robotics Ltd. Announces Closing of $15 Million Underwritten Registered Direct Offering</title>
      <description>TEL AVIV, ISRAEL, Sept.  28, 2026  (GLOBE NEWSWIRE) --  Arbe Robotics Ltd. (NASDAQ:ARBE), (TASE: ARBE) (&quot;Arbe&quot; or the &quot;Company&quot;), a global leader in ultra-high-resolution radar solutions, today announced the closing of its previously announced underwritten registered direct offering of 833,334 ordinary shares at a purchase price of $0.60 per ordinary share, and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 24,166,666 ordinary shares at a purchase price of $0.5999 per share, which equals the offering price per ordinary share less the $0.0001 exercise price per share of each pre-funded warrant. The pre-funded warrants are immediately exercisable and wi</description>
      <link>https://www.quantisnow.com/insight/arbe-robotics-ltd-announces-closing-of-15-million-underwritten-registered-6727741</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/arbe-robotics-ltd-announces-closing-of-15-million-underwritten-registered-6727741</guid>
      <pubDate>Mon, 28 Sep 2026 20:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Alexandria Real Estate Equities, Inc. Announces Closing of Amended and Restated $5.0 Billion Unsecured Senior Line of Credit</title>
      <description>PASADENA, Calif., Sept. 28, 2026 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) today announced the closing of its amended and restated $5.0 billion unsecured senior line of credit, a strategic extension that further strengthens the company&apos;s long-term financial flexibility and reflects the enduring support of its longstanding, trusted banking partners. The amendment extends the maturity of the facility to January 2032 and reduces the applicable borrowing margin, reinforcing Alexandria&apos;s disciplined and proactive management of its strong and flexible balance sheet. The amended agreement became effective on September 24, 2026.
    
                
                    
     </description>
      <link>https://www.quantisnow.com/insight/alexandria-real-estate-equities-inc-announces-closing-of-amended-and-6727712</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/alexandria-real-estate-equities-inc-announces-closing-of-amended-and-6727712</guid>
      <pubDate>Mon, 28 Sep 2026 20:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Futurewave Acquisition Corporation and Olympian Group Inc. Announce Merger Agreement</title>
      <description>NEW YORK and HONG KONG, Sept.  28, 2026  (GLOBE NEWSWIRE) -- Futurewave Acquisition Corporation (NASDAQ:FWAC) (&quot;Futurewave&quot;), a Cayman Islands special purpose acquisition company, and Olympian Group Inc., a Cayman Islands exempted company (&quot;Olympian&quot;) today announced that they have entered into a definitive Agreement and Plan of Merger dated September 28, 2026 (the &quot;Merger Agreement&quot;). Olympian is a solutions provider through its wholly owned Hong Kong subsidiary, HK Shang Ge Industrial Limited, specializing in integrated chip and electronic component solutions, including product solutions and value-added services in Hong Kong. Upon consummation of the transactions contemplated by the Merger</description>
      <link>https://www.quantisnow.com/insight/futurewave-acquisition-corporation-and-olympian-group-inc-announce-merger-agreement-6727704</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/futurewave-acquisition-corporation-and-olympian-group-inc-announce-merger-agreement-6727704</guid>
      <pubDate>Mon, 28 Sep 2026 20:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Cibus and Crystal Crop Protection Team Up to Improve India’s Mustard Crop</title>
      <description>SAN DIEGO and NEW DELHI, Sept.  28, 2026  (GLOBE NEWSWIRE) -- Crystal Crop Protection Limited (&quot;Crystal Crop&quot;), an Indian crop solutions company, and Cibus, Inc. (NASDAQ:CBUS) a technology company that uses biology to produce sustainable ingredients and helps farmers grow more food with fewer inputs, today announced an agreement to develop gene-edited traits in Brassica juncea (&quot;Mustard&quot;). Mustard is the oilseed at the heart of Indian cooking, and India grows more of it than any other country, on roughly 8.5 million hectares (21 million acres). Even so, India imports more than half of the edible oil it consumes, roughly 17 million tonnes a year, most of it palm and soybean oil. A better-perf</description>
      <link>https://www.quantisnow.com/insight/cibus-and-crystal-crop-protection-team-up-to-improve-indias-6727653</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cibus-and-crystal-crop-protection-team-up-to-improve-indias-6727653</guid>
      <pubDate>Mon, 28 Sep 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Star Fashion Culture Holdings Limited  Announces Closing of Approximately US$9,600,000 Public Offering of Class A Ordinary Shares</title>
      <description>XIAMEN, Sept.  28, 2026  (GLOBE NEWSWIRE) --  STAR FASHION CULTURE HOLDINGS LIMITED (NASDAQ:STFS) (the &quot;Company&quot; or &quot;STFS&quot;) today announced the Closing of its best-efforts follow-on public offering on September 28, 2026 of 12,000,000 Class A ordinary shares at a public offering price of $0.80 per Class A ordinary share (the &quot;Offering&quot;).  Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $9,600,000. The Company intends to use the net proceeds of this offering for developing its online marketing services and for general administration and working capital.  Kingswood Capital Partners, LLC acted as the placement agent (the &quot;Placem</description>
      <link>https://www.quantisnow.com/insight/star-fashion-culture-holdings-limited-announces-closing-of-approximately-us9600000-6727606</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/star-fashion-culture-holdings-limited-announces-closing-of-approximately-us9600000-6727606</guid>
      <pubDate>Mon, 28 Sep 2026 20:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Burke &amp; Herbert Financial Services Corp. Prices $100.0 Million Subordinated Notes Offering</title>
      <description>ALEXANDRIA, Va., Sept.  28, 2026  (GLOBE NEWSWIRE) -- Burke &amp; Herbert Financial Services Corp. (the &quot;Company&quot;) (NASDAQ:BHRB), the holding company for Burke &amp; Herbert Bank &amp; Trust Company (the &quot;Bank&quot;), today announced the pricing of its public offering of $100.0 million aggregate principal amount of its 7.00% Fixed-to-Floating Rate Subordinated Notes due 2036 (the &quot;Notes&quot;). The price to the public for the Notes is 100% of the principal amount of the Notes. The Notes will mature on October 1, 2036. Interest on the Notes initially will accrue at a rate equal to 7.00% per annum from and including September 30, 2026 to, but excluding, October 1, 2031, payable semiannually in arrears. From and inc</description>
      <link>https://www.quantisnow.com/insight/burke-herbert-financial-services-corp-prices-1000-million-subordinated-notes-6727598</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/burke-herbert-financial-services-corp-prices-1000-million-subordinated-notes-6727598</guid>
      <pubDate>Mon, 28 Sep 2026 19:36:59 GMT</pubDate>
    </item>
    <item>
      <title>4 Explosive Stories Enter the Investor Spotlight</title>
      <description>DENVER, Sept.  28, 2026  (GLOBE NEWSWIRE) -- (247marketnews.com) -- Kodiak Sciences (NASDAQ:KOD), NeOnc Technologies Holdings (NASDAQ:NTHI), DataMeds AI (NASDAQ:MEDS), and KNOREX (NYSEAMERICAN:KNRX) are each approaching important milestones that could reshape how investors view their pipelines, platforms and near-term prospects.  Kodiak Sciences: Five Phase 3 Wins Put Zenkuda on the Regulatory Runway  Kodiak Sciences (NASDAQ:KOD) delivered one of the biggest clinical updates in the group. Its pivotal Phase 3 DAYBREAK study produced positive primary-endpoint results for both Zenkuda and tabirafusp-ted in wet age-related macular degeneration. Zenkuda achieved non-inferiority to aflibercept on </description>
      <link>https://www.quantisnow.com/insight/4-explosive-stories-enter-the-investor-spotlight-6727491</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/4-explosive-stories-enter-the-investor-spotlight-6727491</guid>
      <pubDate>Mon, 28 Sep 2026 15:51:09 GMT</pubDate>
    </item>
    <item>
      <title>Powerful NeOnc Brain Cancer Pipeline Advances</title>
      <description>DENVER, Sept.  28, 2026  (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is putting another major date on the biotech calendar: November 17, 2026, when the company is scheduled to meet with the U.S. Food and Drug Administration for an in-person End-of-Phase 1 Type B meeting covering its experimental brain-cancer drug NEO212.  The meeting could become an important inflection point for a company that has rapidly assembled a string of clinical, regulatory and Wall Street catalysts.  NeOnc says it plans to seek FDA feedback on NEO212’s proposed patient population, trial design, endpoints, dose selection and the evidence that could ultimately support a marketi</description>
      <link>https://www.quantisnow.com/insight/powerful-neonc-brain-cancer-pipeline-advances-6727397</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/powerful-neonc-brain-cancer-pipeline-advances-6727397</guid>
      <pubDate>Mon, 28 Sep 2026 13:51:14 GMT</pubDate>
    </item>
    <item>
      <title>MBody AI Presents AI Robot Workforce Platform at Lytham Fall 2026 Conference</title>
      <description>  LAS VEGAS, Sept.  28, 2026  (GLOBE NEWSWIRE) -- MBody AI Ltd. (&quot;MBody AI&quot; or the &quot;Company&quot;) (NASDAQ:MBAI) today announced that Chief Executive Officer John Fowler will present at the Lytham Partners Fall 2026 Investor Conference, held virtually September 29 and 30.  Mr. Fowler will host a fireside chat on Tuesday, September 29 at 2:30 p.m. ET. Management will hold one-on-one meetings with investors across both days of the conference.  MBody AI enters the conference with autonomous robot fleets operating in eleven U.S. states, up from nine in June 2026, plus a fleet in Canada. The Company&apos;s fleets have serviced approximately 600 million square feet cumulatively. Capital from the Company&apos;s A</description>
      <link>https://www.quantisnow.com/insight/mbody-ai-presents-ai-robot-workforce-platform-at-lytham-fall-6727270</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/mbody-ai-presents-ai-robot-workforce-platform-at-lytham-fall-6727270</guid>
      <pubDate>Mon, 28 Sep 2026 12:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Century Casinos, Inc. Enters into Definitive Agreement to Sell Century Mile and Century Downs Racetracks in Alberta, Canada</title>
      <description>COLORADO SPRINGS, Colo., Sept. 28, 2026 /PRNewswire/ -- Century Casinos, Inc. (Nasdaq Capital Market®: CNTY) (&quot;Century Casinos&quot; or the &quot;Company&quot;) announced today that it has entered into a definitive agreement to sell the racing and gaming operations of Century Mile Racetrack and Casino in Edmonton, Alberta (&quot;Century Mile&quot;) and Century Downs Racetrack and Casino in Calgary, Alberta (&quot;Century Downs&quot;) to Highfield Investment Group (&quot;Highfield&quot; or the &quot;Buyer&quot;) for an aggregate purchase price of approximately $16.4 million (CAD 23.2 million based on the exchange rate of 0.7074 CAD/USD on September 27, 2026), representing a 6.1x multiple of FY 2025 EBITDA.
    
                
                  </description>
      <link>https://www.quantisnow.com/insight/century-casinos-inc-enters-into-definitive-agreement-to-sell-century-6727173</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/century-casinos-inc-enters-into-definitive-agreement-to-sell-century-6727173</guid>
      <pubDate>Mon, 28 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Astro Digital, Premier Builder of Satellites for Commercial, Civil and Defense Applications, to Become Public Through Merger with Proem Acquisition Corp I</title>
      <description>Since 2018, Astro Digital has delivered nearly 40 satellites across 16 mission types for more than 30 customers, including NASA, the Department of Defense, Boeing, and Sony.  Astro Digital grew revenue at a 42% two-year CAGR while generating positive adjusted EBITDA, a rare combination among public space peers.  $50 million PIPE with Proem Asset Management and its affiliates committing $25 million, co-led with Leon Capital Group  Proem Asset Management is led by Imran Khan, former Chief Strategy Officer of Snap; following closing, Imran Khan will join the board of directors of Astro Digital.  DENVER, CO and DALLAS, TX, Sept.  28, 2026  (GLOBE NEWSWIRE) --  Astro Digital, US, Inc. (&quot;Astro Dig</description>
      <link>https://www.quantisnow.com/insight/astro-digital-premier-builder-of-satellites-for-commercial-civil-and-6727124</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/astro-digital-premier-builder-of-satellites-for-commercial-civil-and-6727124</guid>
      <pubDate>Mon, 28 Sep 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Draganfly Announces Strategic Investment from Unusual Machines and a Leading U.S. Investment Fund</title>
      <description>Unusual Machines (NYSE:UMAC) and a leading U.S. Investment Fund make a strategic investment of $10M, each investing $5M into Draganfly, in support of the Company’s growing position in the U.S. defense ecosystem while also gaining access to strategic opportunities in international markets uniquely served by Draganfly.  TAMPA, Fla., Sept.  28, 2026  (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8) (&quot;Draganfly&quot; or the &quot;Company&quot;), an industry-leading developer of drone solutions, systems and technologies, announces a US$10 million strategic investment by Unusual Machines, Inc. (NYSE:UMAC) and a leading U.S. Investment Fund, each investing $5M (the &quot;Investment&quot;).  This strat</description>
      <link>https://www.quantisnow.com/insight/draganfly-announces-strategic-investment-from-unusual-machines-and-a-leading-6727105</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/draganfly-announces-strategic-investment-from-unusual-machines-and-a-leading-6727105</guid>
      <pubDate>Mon, 28 Sep 2026 11:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Churchill Downs Incorporated Announces Closing of Amended and Extended Credit Facility and New Term Loan B</title>
      <description>LOUISVILLE, Ky., Sept.  28, 2026  (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (NASDAQ:CHDN, &quot;CDI, &quot; &quot;the Company&quot;)) announced today that CDI successfully closed its amended and extended Credit Facility and new Term Loan B (&quot;2033 TLB&quot;).  CDI closed an amendment to its senior secured credit agreement (the &quot;Credit Agreement Amendment&quot;) to extend the maturity date of its existing revolving credit facility and term loan A facility from 2029 to 2031 and to make certain other changes to its existing credit agreement.   The interest rate applicable to borrowings on the Credit Agreement Amendment will be SOFR-based plus a spread, determined by CDI&apos;s total net leverage ratio.  CDI also closed its</description>
      <link>https://www.quantisnow.com/insight/churchill-downs-incorporated-announces-closing-of-amended-and-extended-credit-6727036</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/churchill-downs-incorporated-announces-closing-of-amended-and-extended-credit-6727036</guid>
      <pubDate>Mon, 28 Sep 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>JAGUAR URANIUM TO PARTICIPATE IN ROTH CAPITAL PARTNERS&apos; EMERGING NUCLEAR TECHNOLOGY CONFERENCE IN NEW YORK</title>
      <description>TORONTO, Sept. 28, 2026 /CNW/ -- Jaguar Uranium Corp. (NYSE American: JAGU) (&quot;Jaguar&quot; or the &quot;Company&quot;) is pleased to announce that it will participate in the ROTH Capital Partners&apos; inaugural Emerging Nuclear Technology Conference on October 1, 2026, in New York City.
    
                
                    
                
    
Jaguar management will discuss:Ongoing exploration progress and recent successes across its wholly owned portfolio of four uranium, rare earth and copper assets across Argentina and Colombia, including brownfield and former mining assets and districts.An overview of the Company&apos;s exploration strategy, 2027 plans and the significant potential of its South American </description>
      <link>https://www.quantisnow.com/insight/jaguar-uranium-to-participate-in-roth-capital-partners-emerging-nuclear-6727026</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/jaguar-uranium-to-participate-in-roth-capital-partners-emerging-nuclear-6727026</guid>
      <pubDate>Mon, 28 Sep 2026 10:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Bimergen Energy Board Authorizes Warrant Buyback Program</title>
      <description>NEWPORT BEACH, CA, Sept.  28, 2026  (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (NYSE:BESS) (&quot;Bimergen&quot;), a U.S. energy infrastructure developer, owner and operator, announces that its Board of Directors has authorized an open-market warrant repurchase program to buyback any or all its publicly traded warrants (Ticker: BESSWS).  The program aims to opportunistically deploy capital to reduce future equity dilution while capitalizing on the then current market pricing. Under the authorization, the Company may purchase warrants from time to time on the open market, through block trades, or via privately negotiated transactions in each case in compliance with applicable federal securities la</description>
      <link>https://www.quantisnow.com/insight/bimergen-energy-board-authorizes-warrant-buyback-program-6727000</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/bimergen-energy-board-authorizes-warrant-buyback-program-6727000</guid>
      <pubDate>Mon, 28 Sep 2026 10:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Future Money Acquisition Corporation Announces Receipt of Nasdaq Delinquency Notice Regarding Delayed Form 10-Q Filing</title>
      <description>San Francisco, CA, Sept.  25, 2026  (GLOBE NEWSWIRE) -- Future Money Acquisition Corporation (NASDAQ:FMAC) (the &quot;Company&quot;) announced today that on September 22, 2026, the Company received a deficiency letter (the &quot;Notice&quot;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&quot;Nasdaq&quot;) notifying the Company that, because it has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2026 (the &quot;Form 10-Q&quot;), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.  The Notice states that the Company has 6</description>
      <link>https://www.quantisnow.com/insight/future-money-acquisition-corporation-announces-receipt-of-nasdaq-delinquency-notice-6726685</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/future-money-acquisition-corporation-announces-receipt-of-nasdaq-delinquency-notice-6726685</guid>
      <pubDate>Fri, 25 Sep 2026 21:00:00 GMT</pubDate>
    </item>
    <item>
      <title>CleanSpark, Inc. Announces Closing of $2.276 Billion of Senior Secured Notes</title>
      <description>LAS VEGAS, Sept. 25, 2026 /PRNewswire/ -- CleanSpark, Inc. (NASDAQ:CLSK) (&quot;CleanSpark&quot; or the &quot;Company&quot;), a market-leading data center developer, today announced that its wholly owned subsidiary, CSDC Finance I, LLC, has closed its previously announced offering of $2.276 billion aggregate principal amount of 7.875% senior secured notes due 2031.
    
                
                    
                
    
The notes have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from registration. About CleanSparkCleanSpark is a market-leading data center developer with a proven track record of su</description>
      <link>https://www.quantisnow.com/insight/cleanspark-inc-announces-closing-of-2276-billion-of-senior-secured-6726663</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cleanspark-inc-announces-closing-of-2276-billion-of-senior-secured-6726663</guid>
      <pubDate>Fri, 25 Sep 2026 20:48:00 GMT</pubDate>
    </item>
    <item>
      <title>Circle Announces CFO Transition Plan</title>
      <description>
Jeremy Fox-Geen to step down as Chief Financial Officer and will support a smooth transition; Company has commenced the search for a successor


Circle Internet Group, Inc. (NYSE:CRCL) today announced that Jeremy Fox-Geen intends to step down as Chief Financial Officer after more than five years in the role. To assist with a smooth transition, he will continue as Chief Financial Officer through the end of December 2026, unless a successor is appointed sooner.


The company has commenced a search for Circle&apos;s next Chief Financial Officer with the assistance of a leading executive search firm.


Since joining Circle in May 2021, Mr. Fox-Geen has played key roles in Circle’s growth and success</description>
      <link>https://www.quantisnow.com/insight/circle-announces-cfo-transition-plan-6726369</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/circle-announces-cfo-transition-plan-6726369</guid>
      <pubDate>Fri, 25 Sep 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Sysco Announces Closing of C$1.5 Billion Senior Notes Offering</title>
      <description>HOUSTON, Sept.  25, 2026  (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) (&quot;Sysco&quot; or the &quot;Company&quot;) today announced that Sysco and Sysco Holdings Corporation, a Delaware corporation and wholly-owned subsidiary of Sysco (&quot;Sysco Holdings&quot; and, together with Sysco, the &quot;Issuers&quot;), have closed a public offering (the &quot;Offering&quot;) of C$1.5 billion in aggregate principal amount of senior notes consisting of the following securities:  C$750 million in aggregate principal amount of 4.250% Senior Notes due 2030 (the &quot;2030 Notes&quot;); andC$750 million in aggregate principal amount of 4.800% Senior Notes due 2034 (the &quot;2034 Notes&quot; and, together with the 2030 Notes, the &quot;Notes&quot;).  The Issuers estimate that</description>
      <link>https://www.quantisnow.com/insight/sysco-announces-closing-of-c15-billion-senior-notes-offering-6726362</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sysco-announces-closing-of-c15-billion-senior-notes-offering-6726362</guid>
      <pubDate>Fri, 25 Sep 2026 20:01:00 GMT</pubDate>
    </item>
  </channel>
</rss>